Albuterol adverse reactions
Pro Research Analysisby 
Searched over 200M research papers
Common Adverse Reactions to Albuterol: Asthma and General Use
Albuterol is widely used for asthma and other respiratory conditions. In clinical studies, the most common adverse reactions reported with albuterol use include upper respiratory tract infections, nasopharyngitis, headache, and sinusitis. These events occurred at similar or even lower rates compared to placebo, and most were mild in nature. The incidence of beta2-agonist-related side effects, such as tremor or palpitations, was low (≤1%) in both short-term and long-term use studies, indicating a generally favorable safety profile for albuterol in patients with asthma .
Serious and Rare Adverse Effects: Cardiac and Hypersensitivity Reactions
While albuterol is generally safe, rare but serious adverse reactions have been reported. These include tachyarrhythmias, especially in patients with underlying cardiac conditions such as Wolff-Parkinson-White syndrome, where albuterol inhalation has been associated with life-threatening arrhythmias . There is also a case report of Stevens-Johnson Syndrome (SJS), a severe skin reaction, temporally associated with albuterol use in a child, suggesting that clinicians should be vigilant for rare hypersensitivity reactions .
Paradoxical Bronchospasm and Laryngospasm
Although albuterol is intended to relieve bronchospasm, paradoxical bronchoconstriction and laryngospasm have been reported, particularly with repeated doses of nebulizer solutions containing edetate disodium. These reactions are rare but can be severe, requiring immediate intervention .
Metabolic and Systemic Side Effects
Albuterol can cause dose-related metabolic effects, including decreased plasma potassium, phosphate, calcium, and magnesium, as well as increased plasma glucose, insulin, renin, lactate, and ketones. Other systemic effects include peripheral vasodilation, increased pulse pressure, tachycardia, and skeletal muscle tremor. These side effects are more common with higher systemic exposure, such as with oral or intravenous administration, and are less prominent with inhaled forms .
Genetic Factors Influencing Adverse Reactions
Some patients may experience adverse effects due to genetic differences. Specifically, individuals with certain beta2-adrenergic receptor polymorphisms (Arg/Arg at codon 16) may have a decline in lung function with regular albuterol use, while others do not show this effect. This suggests that genetic testing could help identify patients at higher risk for adverse reactions with regular albuterol therapy Israel2001Israel2000.
Albuterol in Perioperative Settings: Reducing Respiratory Adverse Events
In children undergoing tonsillectomy, albuterol premedication has been shown to significantly reduce the risk of perioperative respiratory adverse events such as laryngospasm, coughing, and oxygen desaturation compared to placebo. This suggests a protective effect in high-risk pediatric surgical populations, with no increase in adverse reactions reported in these studies 2Von Ungern-Sternberg2019.
Albuterol and Vasoactive Agents in Critical Care
In critically ill patients, the combination of albuterol with intravenous vasoactive medications may be associated with fewer ventilator-free and ICU-free days, though no significant increase in cardiac adverse events was observed. This highlights the need for careful monitoring and further research on the additive effects of beta-agonists in this setting .
Conclusion
Albuterol is generally well-tolerated, with most adverse reactions being mild and infrequent. However, clinicians should be aware of rare but serious risks such as arrhythmias, paradoxical bronchospasm, and hypersensitivity reactions. Genetic factors may influence individual responses, and special caution is warranted in patients with underlying cardiac conditions or when used in combination with other beta-agonist agents. Overall, the safety profile of albuterol remains favorable for most patients when used as directed Raphael2015Mutlu2000Kroesen2012+5 MORE.
Sources and full results
Most relevant research papers on this topic